10.08.2013 Views

Hyperbare Zuurstoftherapie: Rapid Assessment - KCE

Hyperbare Zuurstoftherapie: Rapid Assessment - KCE

Hyperbare Zuurstoftherapie: Rapid Assessment - KCE

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

40 Hyperbaric Oxygenation Therapy <strong>KCE</strong> Reports 74<br />

4 REVIEW OF ECONOMIC STUDIES<br />

4.1 INTRODUCTION<br />

In this chapter we provide a systematic literature review and a detailed and critical<br />

appraisal of results. The objective is to determine if adjuvant HBOT is a cost-effective<br />

option compared with standard care for several indications.<br />

4.2 METHODS<br />

4.2.1 Literature search strategy<br />

A comprehensive review of the literature was undertaken to identify all literature that<br />

may provide evidence with regard to the cost effectiveness of HBOT. Websites of HTA<br />

institutes and electronic databases were searched.<br />

4.2.1.1 HTA institute reports<br />

As a starting point, websites of HTA institutes were consulted. The search of<br />

INAHTA’s (International Network of Agencies for Health Technology <strong>Assessment</strong>)<br />

HTA database helped to identify assessment reports issued by national or regional HTA<br />

agencies on HBOT. This consultation was completed by a manual search for reports<br />

regarding HBOT on the websites of HTA institutes mentioned on the INAHTA<br />

website. This search was performed independently by two researchers (CO and MN).<br />

The final search was performed on January 3, 2008.<br />

4.2.1.2 Electronic databases<br />

In January 2008, databases were searched to identify all relevant HTA reports,<br />

systematic reviews and full economic evaluations measuring the cost-effectiveness of<br />

HBOT. The following electronic databases were consulted: Medline, Embase, Centre for<br />

Reviews and Dissemination (CRD) databases (Database of Abstracts of Reviews of<br />

Effects (DARE), NHS Economic Evaluation Database (NHS EED), and Health<br />

Technology <strong>Assessment</strong>s (HTA)), Cochrane Database of Systematic Reviews (CDSR),<br />

and Econlit. No restrictions on the time period and language were imposed. An<br />

overview of the search strategy and results are provided in appendix.<br />

4.2.2 Selection criteria<br />

All returned references were assessed based on title, abstract and keywords. When no<br />

abstract was available or the reference was unclear or ambiguous, consideration of the<br />

reference was made on the basis of full-text assessment. Reference lists of retrieved<br />

papers were checked for additional relevant references. This whole literature search<br />

and selection procedure was repeated by a second reviewer to assess the quality of this<br />

process.<br />

Papers fulfilling several selection criteria were included in the economic review. Full<br />

economic evaluations that compare two or more alternatives and consider both costs<br />

and consequences, including cost-effectiveness, cost-utility and cost-benefit analysis,<br />

were eligible. The outcomes should be expressed as costs per life-years gained (LYG),<br />

costs per quality-adjusted life years (QALYs) gained, or any other appropriate diseasespecific<br />

health outcome. The latter refers to e.g. the cost per amputation avoided.<br />

Other types of studies, such as cost descriptions or cost comparisons were not seen as<br />

full economic evaluations (Figure 21).

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!